Book contents
- Placental–Fetal Growth Restriction
- Placental–Fetal Growth Restriction
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Glossary and Commonly Used Abbreviations
- Section 1 Basic Principles
- Section 2 Maternal Cardiovascular Characteristics and the Placenta
- Section 3 Screening for Placental–Fetal Growth Restriction
- Chapter 11 First Trimester Combined Screening Algorithms for Fetal Growth Restriction
- Chapter 12 Second Trimester and Late-Pregnancy Screening for Fetal Growth Restriction
- Section 4 Prophylaxis and Treatment
- Section 5 Characteristics of Fetal Growth Restriction
- Section 6 Management of Fetal Growth Restriction
- Section 7 Postnatal Aspects of Fetal Growth Restriction
- Index
- References
Chapter 11 - First Trimester Combined Screening Algorithms for Fetal Growth Restriction
from Section 3 - Screening for Placental–Fetal Growth Restriction
Published online by Cambridge University Press: 23 July 2018
Book contents
- Placental–Fetal Growth Restriction
- Placental–Fetal Growth Restriction
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Glossary and Commonly Used Abbreviations
- Section 1 Basic Principles
- Section 2 Maternal Cardiovascular Characteristics and the Placenta
- Section 3 Screening for Placental–Fetal Growth Restriction
- Chapter 11 First Trimester Combined Screening Algorithms for Fetal Growth Restriction
- Chapter 12 Second Trimester and Late-Pregnancy Screening for Fetal Growth Restriction
- Section 4 Prophylaxis and Treatment
- Section 5 Characteristics of Fetal Growth Restriction
- Section 6 Management of Fetal Growth Restriction
- Section 7 Postnatal Aspects of Fetal Growth Restriction
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Placental-Fetal Growth Restriction , pp. 95 - 104Publisher: Cambridge University PressPrint publication year: 2018
References
Dukhovny, S, Zera, C, Little, SE, McElrath, T, Wilkins-Haug, L. Eliminating first trimester markers: Will replacing PAPP-A and βhCG miss women at risk for small for gestational age? J Matern Fetal Neonatal Med 2014.Google Scholar
Nicolaides, KH, Wright, D, Poon, LC, Syngelaki, A, Gil, MM. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013 Jul;42(1):41–50.Google Scholar
The Investigation and Management of the Small-for-Gestational-Age Fetus: Greentop Guideline 31. Royal College of Obstetricians and Gynaecologists, London, UK; 2013.Google Scholar
Cnossen, JS, Morris, RK, Ter Riet, G, Mol, BWJ, Van der Post, JAM, Coomarasamy, A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: A systematic review and bivariable meta-analysis. CMAJ 2008 Mar 11;178(6):701–11.Google Scholar
Verlohren, S, Melchiorre, K, Khalil, A, Thilaganathan, B. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: Providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet Gynecol 2014 Oct;44(3):293–8.Google Scholar
Mayer, C, Joseph, KS. Fetal growth: A review of terms, concepts and issues relevant to obstetrics. Ultrasound Obstet Gynecol 2013 Feb;41(2):136–45.Google Scholar
Gardosi, J, Madurasinghe, V, Williams, M, Malik, A, Francis, A. Maternal and fetal risk factors for stillbirth: Population based study. BMJ 2013;346:f108.Google Scholar
Lindqvist, PG, Molin, J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005 Mar;25(3):258–64.Google Scholar
Roberge, S, Nicolaides, KH, Demers, S, Villa, P, Bujold, E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis. Ultrasound Obstet Gynecol 2013;41:491–9.Google Scholar
Sanz-Cortés, M, Carbajo, RJ, Crispi, F, Figueras, F, Pineda-Lucena, A, Gratacós, E. Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation. PLoS One 2013 Jan;8(12):e801217.Google Scholar
Mifsud, W, Sebire, NJ. Placental pathology in early-onset and late-onset fetal growth restriction. Fetal Diagn Ther 2014 Jan;36(2):117–28.Google Scholar
Kovo, M, Schreiber, L, Ben-Haroush, A, Wand, S, Golan, A, Bar, J. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol 2010 Jul;202(6):561.e1–5.Google Scholar
Schwartz, N, Sammel, MD, Leite, R, Parry, S. First-trimester placental ultrasound and maternal serum markers as predictors of small-for-gestational-age infants. Am J Obstet Gynecol Elsevier; 2014 Sep 9;211(3):253.e1–8.Google Scholar
Romero, R, Kusanovic, JP, Than, NG, Erez, O, Gotsch, F, Espinoza, J, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol Elsevier; 2008 Aug 8;199(2):122.e1–122.e11.Google Scholar
Stamatopoulou, A, Cowans, NJ, Matwejew, E, Von Kaisenberg, C, Spencer, K. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes. Hypertens Pregnancy 2011:384–95.Google Scholar
Schneuer, FJ, Nassar, N, Khambalia, AZ, Tasevski, V, Ashton, AW, Morris, JM, et al. First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: In-house study and systematic review. Placenta 2012;33:735–40.Google Scholar
Cowans, NJ, Stamatopoulou, A, Khalil, A, Spencer, K. PP13 as a marker of pre-eclampsia: A two platform comparison study. Placenta 2011;32.Google Scholar
Plasencia, W, Akolekar, R, Dagklis, T, Veduta, A, Nicolaides, KH. Placental volume at 11–13 weeks’ gestation in the prediction of birth weight percentile. Fetal Diagn Ther 2011;30:23–8.Google Scholar
Odibo, AO, Patel, KR, Spitalnik, A, Odibo, L, Huettner, P. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol 2014;34:186–91.Google Scholar
Spencer, K, Cowans, NJ, Avgidou, K, Molina, F, Nicolaides, KH. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008;31:15–19.Google Scholar
D’Antonio, F, Rijo, C, Thilaganathan, B, Akolekar, R, Khalil, A, Papageourgiou, A, et al. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications. Prenat Diagn 2013 Sep;33(9):839–47.Google Scholar
Dugoff, L, Hobbins, JC, Malone, FD, Porter, TF, Luthy, D, Comstock, CH, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial). Am J Obstet Gynecol 2004:1446–51.Google Scholar
Karagiannis, G, Akolekar, R, Sarquis, R, Wright, D, Nicolaides, KH. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011;29:148–54.Google Scholar
Wortelboer, EJ, Koster, MPH, Kuc, S, Eijkemans, MJC, Bilardo, CM, Schielen, PCJI, et al. Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy. Ultrasound Obstet Gynecol 2011 Oct;38(4):383–8.Google Scholar
Yang, J, Wu, J, Guo, F, Wang, D, Chen, K, Li, J, et al. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes. PLoS One 2014 Jan 15;9(5):e97284.Google Scholar
Poon, LCY, Chelemen, T, Granvillano, O, Pandeva, I, Nicolaides, KH. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol 2008 Nov;112(5):1082–90.Google Scholar
Lacroix, MC, Guibourdenche, J, Frendo, JL, Muller, F, Evain-Brion, D. Human placental growth hormone – a review. Placenta 2002 Apr;23 Suppl A:S87–94.Google Scholar
Sifakis, S, Akolekar, R, Kappou, D, Mantas, N, Nicolaides, KH. Maternal serum placental growth hormone at 11–13 weeks’ gestation in pregnancies delivering small for gestational age neonates. J Matern Fetal Neonatal Med 2012:1796–9.Google Scholar
Romero, R, Nien, JK, Espinoza, J, Todem, D, Fu, W, Chung, H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for. J Matern Fetal Neonatal Med 2008 Jan;21(1):9–23.Google Scholar
Poon, L, Zaragoza, E, Akolekar, R, Anagnostopoulos, E, Nicolaides, KH. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Prenat Diagn 2008;28:1110–15.Google Scholar
Dessì, A, Marincola, F, Fanos, V. Metabolomics and the great obstetrical syndromes – GDM, PET, and IUGR. Best Pract Res Clin Obstet Gynaecol 2014 Aug 21;29(2):156–64.Google Scholar
Dessì, A, Atzori, L, Noto, A, Visser, GHA, Gazzolo, D, Zanardo, V, et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): Urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011 Oct;24 Suppl 2:35–9.Google Scholar
Barker, DJ, Gluckman, PD, Godfrey, KM, Harding, JE, Owens, JA, Robinson, JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993 Apr 10;341(8850):938–41.Google Scholar
Barberini, L, Noto, A, Fattuoni, C, Grapov, D, Casanova, A, Fenu, G, et al. Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth. J Matern Fetal Neonatal Med 2014 Oct;27 Suppl 2:20–6.Google Scholar
Lin, G, Liu, C, Feng, C, Fan, Z, Dai, Z, Lai, C, et al. Metabolomic analysis reveals differences in umbilical vein plasma metabolites between normal and growth-restricted fetal pigs during late gestation. J Nutr 2012 Jun;142(6):990–8.Google Scholar
Favretto, D, Cosmi, E, Ragazzi, E, Visentin, S, Tucci, M, Fais, P, et al. Cord blood metabolomic profiling in intrauterine growth restriction. Anal Bioanal Chem 2012 Jan;402(3):1109–21.Google Scholar
Van Vliet, E, Eixarch, E, Illa, M, Arbat-Plana, A, González-Tendero, A, Hogberg, HT, et al. Metabolomics reveals metabolic alterations by intrauterine growth restriction in the fetal rabbit brain. PLoS One 2013 Jan;8(5):e64545.Google Scholar
Heazell, AEP, Brown, M, Worton, SA, Dunn, WB. Review: The effects of oxygen on normal and pre-eclamptic placental tissue – insights from metabolomics. Placenta 2011 Mar 32 Suppl 2:S119–24.Google Scholar
Diaz, SO, Barros, AS, Goodfellow, BJ, Duarte, IF, Galhano, E, Pita, C, et al. Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res American Chemical Society 2013 Jun 7;12(6):2946–57.Google Scholar
Maitre, L, Fthenou, E, Athersuch, T, Coen, M, Toledano, MB, Holmes, E, et al. Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother-child cohort study. BMC Med 2014 Jan;12:110.Google Scholar
Sulek, K, Han, T-L, Villas-Boas, SG, Wishart, DS, Soh, S-E, Kwek, K, et al. Hair metabolomics: Identification of fetal compromise provides proof of concept for biomarker discovery. Theranostics 2014 Jan;4(9):953–9.Google Scholar
Onwudiwe, N, Yu, CKH, Poon, LCY, Spiliopoulos, I, Nicolaides, KH. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol 2008 Dec;32(7):877–83.Google Scholar
Hafner, E, Metzenbauer, M, Höfinger, D, Stonek, F, Schuchter, K, Waldhör, T, et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol 2006 Jun;27(6):652–7.Google Scholar
Seravalli, V, Block-Abraham, DM, Turan, OM, Doyle, LE, Kopelman, JN, Atlas, RO, et al. First-trimester prediction of small-for-gestational age neonates incorporating fetal Doppler parameters and maternal characteristics. Am J Obstet Gynecol Elsevier; 2014 Sep 9;211(3):261.e1–8.Google Scholar
Khalil, A, Sodre, D, Syngelaki, A, Akolekar, R, Nicolaides, KH. Maternal hemodynamics at 11–13 weeks of gestation in pregnancies delivering small for gestational age neonates. Fetal Diagn Ther 2012 Jan;32(4):231–8.Google Scholar
De Paco, C, Kametas, N, Rencoret, G, Strobl, I, Nicolaides, KH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol 2008;111:292–300.Google Scholar
Poon, LCY, Syngelaki, A, Akolekar, R, Lai, J, Nicolaides, KH. Combined screening for preeclampsia and small for gestational age at 11–13 weeks. Fetal Diagn Ther 2013;33:16–27.Google Scholar
Kane, S, da Silva Costa, B. First trimester biomarkers in the prediction of later pregnancy complications. Biomed Res Int 2014 (Article ID 807196).Google Scholar
Crovetto, F, Crispi, F, Scazzocchio, E, Mercade, I, Meler, E, Figueras, F, et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound Obstet Gynecol 2014;43:34–40.Google Scholar